Work

Supplementary table 4 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Table 4. IC20 and IC50 of different PARP inhibitors in MDAMB231 cell line. IC20 and IC50 were calculated according to the dose-response curves of the different PARP inhibitors using GraphPadPrism software.

DOI: 10.1158/1078-0432.22465796.v1

Authors: Wael Jdey, Sylvain Thierry, Christophe Russo, Flavien Devun, Muthana Al Abo, Patricia Noguiez-Hellin, Jian-Sheng Sun, Emmanuel Barillot, Andrei Zinovyev, Inna Kuperstein, Yves Pommier, Marie Dutreix

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361818219

Cites:

Cited by:

Related to: 10